International Conferences

Recommended Conferences for Lipoprotein translation

Lipoprotein translation

---

As per the available reports of about 10 Journals, 6 Conferences,and 4 National symposiums related to lipoprotein translational and 10 articles have been published by the Omics International.Apo lipoprotein B (ApoB) are the primary apo lipoproteins of chylomicrons and low-density lipoproteins (LDL - known commonly by the misnomer "bad cholesterol" when in reference to heart disease), which is responsible for carrying cholesterol to tissues.

Scope & Importance

While it is unclear exactly what functional role ApoB plays in LDL, it is the primary Apo lipoprotein component and is absolutely required for its formation. What is clear is that the ApoB on the LDL particle acts as a ligand for LDL receptors in various cells throughout the body (i.e. less formally, ApoB "unlocks" the doors to cells and thereby delivers cholesterol to them). Through a mechanism that is not fully understood, high levels of ApoB can lead to plaques that cause vascular disease (atherosclerosis), leading to heart disease. There is considerable evidence that levels of ApoB are a better indicator of heart disease risk than total cholesterol or LDL. However, primarily for historic reasons, cholesterol, and more specifically, LDL-cholesterol, remains the primary lipid test for the risk factor of atherosclerosis.

OMICS Group is the world leader for its scientific related services by organizing more than 300 International Conference across the world with the support from 1000 International scientific societies and institutes and also managing more than 400 peer reviewed open access journals in science, technology and environment. ConferenceSeries organizes scientific conferences on Clinical Sciences, Engineering & Applied Sciences, Life Sciences, Medical Sciences, Omics & Management and Pharmaceutical/Chemistry and it is a perfect platform for global networking. OMICS Group referred journals are well established and more than 30,000 Editorial Board Members. These journals have been provided to the users with the great services for more than 3.5 million readers across the globe. 

Market Analysis

According to a new market report published by Transparency Market Research Dyslipidemia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2015 - 2023” the global dyslipidemia drugs market was valued at USD 17.9 billion in 2014 and is estimated to reach a market worth of USD 6.9 billion in 2023 growing at a CAGR of -10.3% from 2015 to 2023.

The report on global dyslipidemia drugs market studies a wide range of dyslipidemia drugs that are used for the treatment and mitigation of lipid disorders. Dyslipidemia is characterized by elevation of plasma triglycerides, decreased high-density lipoprotein levels, and abnormal level of low density lipoprotein composition. Burden of dyslipidemia is high across the world in terms of mortality, morbidity, and health care expenditure and imposes substantial costs to the health care system globally.

For example, The American Heart Association (AHA) stated that as of 2013, around 98.9 million people in the U.S. (aged 20 and above) have high blood cholesterol level (more than 200 mg/dL), among which approximately 31.9 million people have total blood cholesterol level of 240 mg/dL or higher. Due to this fact, the demand for dyslipidemia drugs such as statins, fibric acid derivatives, omega-3 fatty acid analogs and bile acid resins are increasing among the patient population for the treatment of this disease. Thus, increasing incidence and demand for dyslipidemia drugs will stimulate the market growth globally.

Symposium & Workshops

· CSU Annual Biotechnology Symposium ,Jan 7-9 , 2016 , Hyatt Regency Orange County.
· Keynote Symposia on Molecular and Cellular Biology.
· International Symposium on Lipoprotein and Pathology of Athereoscleosis.

International Conferences

1. Alzheimers Diseases and Dementia Conference,
   August 31-Sep 2 ,2015 ,Toronto ,Canada.
2. Epilepsy Conference,
   September 21-22 , Baltimore ,USA.
3. Lipid Science and Technology Conference,
   November 30- Dec 2 ,2015 , San Francisco ,USA.
4. Translational Medicine Conference,
    October 26-28 , 2015 , Baltimore ,USA.
5. Clinical Chemistry and Laboratory Medicine Conference,
    May 2-3 ,2016 ,Chicago ,USA.
6. Pharmacology and Ethanopharmacology Conference,
    May 2-4 ,2016 ,Chicago ,USA.
7. Weight Loss and Fitness Conference,
   November 21-23,2016 ,Dubai ,UAE.
8. Nutrition Conference
   Oct 26-28,2015,Chicago,USA.
9. Probiotics,Functional and Baby Foods Conference
   November 3-5 ,Valencia ,Spain.
10. Clinical Nutrition Conference,
     November 28-30,2015, San Antonio,USA.
11. Analytical and Bioanalytical Conference,
     September 1- 3, Valencia ,Spain.
12. Biopharmaceutics Conference,
    September 21-22, 2015 ,Baltimore ,MD ,USA.
13. Biologics and Biosimilars Conference,
     October 26-28 ,2015,Baltimore ,USA.
14. Clinical Pharmacy Conference,
    December 7-9 ,2015, Atlanta ,USA.
15. Toxicogenomics and Drug Monitoring Conference,
    August 25-27 ,2015 ,Valencia, Spain.
16. GMP,GCP and Quality Control Conference,
    October 26-28, Hyderabad,India.
17. Hematology and Blood Disorders Conference,
     November 2-4, Atlanta,USA.
18. Public Health and Nutrition Conference,
     March 10-12 ,Madrid, Spain.
19. 40^th Annual Canadian Lipoprotein Conference,
     October 15-18,2015 , Toronto ,Canada.
20. Kern Lipid Conference,
     August 3-5, 2015,Colarado ,USA.

Associations and Societies

·Baker IDI Association

·The European Lipoprotein Club

·Lipoprotein Foundation

·Biochemical Society

·Belgian Medical Genomics Initiative (BE)

·EMBL-European Bioinformatics Institute (UK)

·EMC Corporation (US)

·European Molecular Biology Laboratory (DE)

·European Society of Human Genetics (AT)

·Fitgenes Limited (AU)

·Five3 Genomics (US)

Companies

·Randox Laboratories

·Berkeley HeartLab

·Eurordis

·Sanofi

·Eisai

·Pharmacyclis

·Incyte

·Markansan Pharma Ltd

·MedIndia-Network for Health

·Sanofi-Aventis

·Eli Lilly & Company

·Schering-Plough

·Leerink Swann

·SHC & Associates

·Kalichem Srl

This page will be updated regularly.

This page was last updated on April 20, 2024